Boston, Mass. — Sesen, a new language services company focused exclusively on the life sciences sector, officially launched yesterday with a mission to streamline global communications for pharmaceutical, biotechnology, medical device, and regulatory organizations.
Founded by industry veterans, Sesen offers translation, localization, and AI-enhanced linguistic services tailored to the complex regulatory and scientific requirements of the life sciences field. The company supports multilingual communication across more than 150 languages, combining advanced technology with deep subject-matter expertise.
Central to Sesen’s capabilities is its proprietary AI engine, SesenGPT, which is trained specifically on life sciences terminology. Designed to handle medical and regulatory content, the engine powers hybrid workflows for tasks such as clinical trial translations, pharmacovigilance, and regulatory labeling.
Dr. Vladimir Misik, Vice President of Global Clinical Trial Strategy at Sesen, said the company was founded to overcome persistent language barriers in global healthcare innovation. “We launched Sesen to solve this challenge with unmatched specialization, seamless technology integration, and the linguistic precision this industry demands,” he said.
The company also emphasizes quality assurance, offering regulatory-compliant translations aligned with EMA, FDA, and PMDA guidelines. Sesen holds certifications under ISO 17100, ISO 9001:2015, and ISO 13485:2016, and its linguistic review process is backed by a network of native linguists and MD/PhD medical experts.
“At Sesen, language quality is not an afterthought—it’s built into the DNA of every project,” said Diego Di Leva, Vice President of Global Operations and a certified ISO auditor. “Our quality assurance framework is grounded in international standards and supported by linguists with deep domain expertise, ensuring every deliverable meets the highest regulatory and scientific expectations.”
With an expanding team of in-country reviewers and regulatory consultants, Sesen aims to support life sciences companies in delivering accurate, compliant multilingual content for clinical trials, product launches, and global regulatory submissions.
